Cindy Burman (United States of America)

Pfizer Inc Vaccine Medical Development and Scientific/Clinical Affairs
Dr Burman received her Bachelor of Science in Pharmacy and Doctorate of Pharmacy degrees from Temple University School of Pharmacy, and completed a Pharmacy Practice Residency before joining the faculty at Temple University. She is now a Senior Director in the Pfizer Medical Development, Scientific and Clinical Affairs group where she is the lead for their meningococcal vaccines, Nimenrix, NeisVac-C and Trumenba. Dr Burman has worked at Pfizer for nearly 16 years, during which she has been the US Medical Lead for Prevnar and Prevenar 13, and for the last 7 years has worked with the expansion of Pfizer Meningococcal Vaccines Portfolio.

Moderator of 1 Session

Session Type
Mon, 24.05.2021
Session Time
12:45 - 13:45
Industry Symposia
Session Description

Are there lessons of meningococcal disease lurking in the shadows of the last 100 years? - Supported by Pfizer

Session Description:

This symposium will explore how past world events have influenced meningococcal disease and the role of vaccines in defeating this disease through:

• Reviewing the epidemiology of meningococcal disease over the last 100 years, focusing on lessons for the future.

• Highlighting the key pillars for the global strategy to defeat meningitis by 2030.

• Exploring current vaccine characteristics informing meningococcal vaccine implementation.

Session Icon
Pre-Recorded with Live Q&A